Citation Impact
Citing Papers
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2018
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
2017
What is polypharmacy? A systematic review of definitions
2017 Standout
Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide
2004
Use of BNP Levels in Monitoring Hospitalized Heart Failure Patients with Heart Failure
2003
Clinical Utility of Single-Beat E/e′ Obtained by Simultaneous Recording of Flow and Tissue Doppler Velocities in Atrial Fibrillation With Preserved Systolic Function
2009
N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure
2010
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
2004
Evidence for Functional Heterogeneity of Circulating B-Type Natriuretic Peptide
2007
Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure
2010
Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure
2007
Effects of Immunoadsorption on the nt‐BNP and nt‐ANP Plasma Levels of Patients Suffering From Dilated Cardiomyopathy†
2006
N‐terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
2003
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
B-type natriuretic peptide in cardiovascular disease
2003
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Growing pains: Non‐adherence with the immunosuppressive regimen in adolescent transplant recipients
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Identification of medication non‐adherence factors in adolescent transplant patients: The patient's viewpoint
2007
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
2006 Standout
Relation of Level of B-Type Natriuretic Peptide With Outcomes in Patients With Infective Endocarditis
2010
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
Brain Natriuretic Peptide in the Management of Heart Failure
2004
NT-ProBNP Reduction Percentage During Admission for Acutely Decompensated Heart Failure Predicts Long-Term Cardiovascular Mortality
2005
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients*
2007
The Prognostic Value of Big Endothelin-1 in More Than 2,300 Patients With Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT)
2006
Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy
2013
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
2014
Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification
2007
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
2012
A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure
2007
Cardiorenal Syndrome
2008 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Natriuretic Peptides
2007
An Overview of Heart Rate Variability Metrics and Norms
2017 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
2005 StandoutNobel
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
2006
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
2005
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease
2009
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults
2005
Biomarkers in Heart Failure
2008 Standout
Prognostic value of reduced kidney function and anemia in patients with chronic heart failure
2007
Noncompliance in organ transplant recipients: a literature review
2000
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999
2004 Standout
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
2019 Standout
Prognostic value of endothelial microparticles in patients with heart failure
2010
Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta‐analysis
2009
A prognostic index to predict long‐term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors
2003
Cystatin C and NT‐proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in primary care
2009 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care
2011
Management of MPN beyond JAK2
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
2017
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
2004
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
2016
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Prolonged QTc Interval and High B-Type Natriuretic Peptide Levels Together Predict Mortality in Patients With Advanced Heart Failure
2003
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis
2004
Cardiac Hormones as Diagnostic Tools in Heart Failure
2003
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease
2003
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
MRI of Cardiac Sarcoidosis: Basal and Subepicardial Localization of Myocardial Lesions and Their Effect on Left Ventricular Function
2008
Epidemiology and Genetics of Sudden Cardiac Death
2012
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Very Low Frequency Power of Heart Rate Variability is a Powerful Predictor of Clinical Prognosis in Patients With Congestive Heart Failure
2004
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Abnormalities of Neurohormonal and Cardiac Autonomic Nervous Activities Relate Poorly to Functional Status in Fontan Patients
2004
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Is Noncompliance Among Adolescent Renal Transplant Recipients Inevitable?
2005
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis
2003
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2017
Factors affecting therapeutic compliance: A review from the patient’s perspective
2008 Standout
Works of Karin Strecker being referenced
Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure
2005
Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period
2003
Non-compliance following renal transplantation in children and adolescents
1998
B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
2002
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
2002
Efficacy and Safety Of AOP2014/P1101, a Novel, Investigational Mono-Pegylated Proline-Interferon Alpha-2b, In Patients With Polycythemia Vera (PV): Update On 51 Patients From The Ongoing Phase I/II Peginvera Study
2013
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
2015
Flow-Mediated Vasodilation Predicts Outcome in Patients With Chronic Heart Failure
2005